Guardant Health, Inc. financial data

Symbol
GH on Nasdaq
Industry
Services-Medical Laboratories
Location
3100 Hanover Street, Palo Alto, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 20, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 578 % -6.83%
Quick Ratio 32.4 % +10.3%
Debt-to-equity -4.86K % -590%
Return On Equity 1.31K %
Return On Assets -27.5 % +0.4%
Operating Margin -60 % +40.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 123M shares
Common Stock, Shares, Outstanding 124M shares +1.94%
Entity Public Float 3.4B USD -17.1%
Weighted Average Number of Shares Outstanding, Basic 123M shares +9.61%
Weighted Average Number of Shares Outstanding, Diluted 123M shares +9.61%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 739M USD +31%
Research and Development Expense 348M USD -5.29%
Selling and Marketing Expense 365M USD +23.6%
General and Administrative Expense 180M USD +15.6%
Costs and Expenses 1.18B USD +4.78%
Operating Income (Loss) -444M USD +21.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -435M USD +9.12%
Income Tax Expense (Benefit) 1.28M USD +87.4%
Net Income (Loss) Attributable to Parent -436M USD +8.98%
Earnings Per Share, Basic -3.56 USD/shares +16.8%
Earnings Per Share, Diluted -3.56 USD/shares +16.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 526M USD -53.6%
Accounts Receivable, after Allowance for Credit Loss, Current 110M USD +24.2%
Inventory, Net 71.1M USD +14.7%
Assets, Current 1.06B USD -21.7%
Property, Plant and Equipment, Net 137M USD -5.71%
Operating Lease, Right-of-Use Asset 142M USD -9.74%
Intangible Assets, Net (Excluding Goodwill) 6.76M USD -24.7%
Goodwill 3.29M USD 0%
Other Assets, Noncurrent 37.2M USD -70.1%
Assets 1.49B USD -16.8%
Accounts Payable, Current 38.6M USD -25.5%
Accrued Liabilities, Current 71.7M USD -65.1%
Contract with Customer, Liability, Current 35.5M USD +97.4%
Liabilities, Current 226M USD +9.55%
Contract with Customer, Liability, Noncurrent 6.1M USD +22%
Operating Lease, Liability, Noncurrent 164M USD -11.6%
Other Liabilities, Noncurrent 92.8M USD -3.3%
Liabilities 1.63B USD -0.15%
Accumulated Other Comprehensive Income (Loss), Net of Tax -5.2M USD -41.5%
Retained Earnings (Accumulated Deficit) -2.58B USD -20.4%
Stockholders' Equity Attributable to Parent -140M USD -188%
Liabilities and Equity 1.49B USD -16.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -30.3M USD +59.3%
Net Cash Provided by (Used in) Financing Activities -1.07M USD -25.8%
Net Cash Provided by (Used in) Investing Activities 28.1M USD -82.1%
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 124M shares +1.94%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.43M USD -105%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 630M USD -44.5%
Deferred Tax Assets, Valuation Allowance 696M USD +15.4%
Deferred Tax Assets, Gross 734M USD +12.2%
Operating Lease, Liability 194M USD -9.49%
Depreciation 40.1M USD +0.25%
Payments to Acquire Property, Plant, and Equipment 6.93M USD -7.84%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -659M USD -50.2%
Lessee, Operating Lease, Liability, to be Paid 220M USD -10.7%
Property, Plant and Equipment, Gross 302M USD +11%
Operating Lease, Liability, Current 29.2M USD +4.52%
Lessee, Operating Lease, Liability, to be Paid, Year Two 30.2M USD -9.16%
Lessee, Operating Lease, Liability, to be Paid, Year One 35.7M USD +0.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 26.6M USD -18.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 26.2M USD -7.14%
Deferred Tax Assets, Operating Loss Carryforwards 423M USD +22.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 42.1M USD +13.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 24.3M USD -0.73%
Additional Paid in Capital 2.44B USD +6.06%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 2.2M USD -18.5%
Depreciation, Depletion and Amortization 10.7M USD +3.55%
Deferred Tax Assets, Net of Valuation Allowance 760K USD -27.4%
Share-based Payment Arrangement, Expense 140M USD +54.7%
Interest Expense 2.58M USD +0.08%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%